Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |